11/05/2024
4:48 PM | Gracias Antonio J. (Reporting)
Harmony Biosciences (Issuer)
Sabater Juan A. (Reporting)
Valor Equity Associates IV L.P. (Reporting)
Valor Equity Capital IV LLC (Reporting)
VALOR EQUITY PARTNERS IV L.P. (Reporting)
VALOR EQUITY PARTNERS IV-A L.P. (Reporting)
VALOR EQUITY PARTNERS IV-B L.P. (Reporting)
Valor IV Pharma Holdings, LLC (Reporting)
Valor Management L.P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/05/2024
3:05 PM | Harmony Biosciences (Issuer)
Marshman Fund Trust II (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/01/2024
3:06 PM | Harmony Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/31/2024
3:39 PM | Harmony Biosciences (Filer)
| Form 424B7 | |
10/31/2024
3:45 PM | Dierks Jeffrey (Reporting)
Harmony Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/29/2024
4:27 PM | Harmony Biosciences (Filer)
| Form 424B7 | |
10/29/2024
3:22 PM | Dierks Jeffrey (Reporting)
Harmony Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
|
10/29/2024
7:00 AM | Harmony Biosciences (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/29/2024
6:50 AM | Harmony Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/03/2024
3:32 PM | Dierks Jeffrey (Reporting)
Harmony Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/01/2024
3:35 PM | Dierks Jeffrey (Reporting)
Harmony Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/01/2024
7:45 AM | Harmony Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/30/2024
3:28 PM | Dierks Jeffrey (Reporting)
Harmony Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/06/2024
7:00 AM | Harmony Biosciences (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/31/2024
7:57 AM | Gracias Antonio J. (Reporting)
Harmony Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/31/2024
7:58 AM | Harmony Biosciences (Issuer)
Sender Gary (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/31/2024
7:52 AM | Anastasiou Peter (Reporting)
Harmony Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/31/2024
7:53 AM | Harmony Biosciences (Issuer)
Szyper Linda M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/31/2024
7:54 AM | Harmony Biosciences (Issuer)
Nielsen Jack (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/31/2024
7:54 AM | Graf R. Mark (Reporting)
Harmony Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/31/2024
7:55 AM | Harmony Biosciences (Issuer)
Sabater Juan A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/29/2024
4:01 PM | Harmony Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/03/2024
7:00 AM | Harmony Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/03/2024
7:05 AM | Budur Kumar (Reporting)
Harmony Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/30/2024
7:00 AM | Harmony Biosciences (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/30/2024
6:45 AM | Harmony Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/11/2024
8:44 AM | Harmony Biosciences (Filer)
| Form ARS | |
04/11/2024
7:30 AM | Harmony Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/11/2024
7:17 AM | Harmony Biosciences (Filer)
| Form DEF 14A | |
04/11/2024
7:18 AM | Harmony Biosciences (Filer)
| Form DEFA14A | |
03/18/2024
6:24 PM | Dierks Jeffrey (Reporting)
Harmony Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/15/2024
3:24 PM | Dierks Jeffrey (Reporting)
Harmony Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/11/2024
4:17 PM | Dierks Jeffrey (Reporting)
Harmony Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/08/2024
3:21 PM | Dierks Jeffrey (Reporting)
Harmony Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/28/2024
4:16 PM | Harmony Biosciences (Filer)
| Form 10-K/A | |
02/22/2024
7:00 AM | Harmony Biosciences (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/22/2024
6:45 AM | Harmony Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/13/2024
6:06 PM | Harmony Biosciences (Subject)
Valor IV Pharma Holdings, LLC (Filed by)
| Form SC 13G/A | |
01/24/2024
1:27 PM | BlackRock Inc. (Filed by)
Harmony Biosciences (Subject)
| Form SC 13G/A | |
01/08/2024
7:30 AM | Harmony Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Free HRMY Stock Alerts